Brainsway’s Governance Shake‑Up: Will New Audit & Equity Plans Boost a Declining Neuromodulation Stock?
Brainsway Ltd. (BWAY.TA) faces a governance shift as shareholders meet on 25 Nov 2026 to decide audit, board re‑election, and equity grants amid a 9% monthly decline and uncertain neuromodulation sales. Explore the implications for investors and the…
4 minutes to read
